Aller au contenu principal
Accès ouvert déclaré 2026 article

STAR in a Second: Ultra-High-Dose-Rate Spread-Out Bragg Peak Proton Therapy for Breath-Hold Stereotactic Arrhythmia Radioablation

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Purpose: Stereotactic arrhythmia radioablation (STAR) is a noninvasive treatment option for managing ventricular tachycardia (VT). Combined respiratory and cardiac motion requires management with large target volume margins or motion mitigation techniques. Techniques such as beam gating and breath-holds are limited by low-duty cycles, extending treatment times. We investigate the feasibility of ultra-high-dose-rate (UHDR) proton therapy using a spread-out Bragg peak technique with a conformal energy modulator to achieve respiratory and cardiac motion management within a single breath-hold delivery per beam for cardiac ablation, thereby reducing treatment time without compromising anatomic accuracy. Methods and Materials: Five ventricular tachycardia cases initially treated on linear accelerators with planning target volumes ranging from 118 to 254 cc were retrospectively planned with UHDR protons on an IBA Proteus Plus system with the ConformalFLASH snout. Plans were contoured on full-inspiration computed tomography phase scans to represent breath-hold anatomy and were planned for 25 Gy in 1 fraction. Plan quality metrics included target coverage (D98%, D2%, V95%) and doses to organs at risk (OARs) such as heart, stomach, and esophagus. An in-house RayStation script was developed to estimate total spot delivery time per beam to assess breath-hold feasibility. Times were validated using logfile-based analysis after delivery on the proton beamline. Results: Each plan was optimized using a combination of 2 to 5 proton fields. Target coverage was comparable with clinical photon intensity modulated radiation therapy plan metrics, demonstrating average (D98%: 2365 cGy [RBE], D2%: 2957 cGy [RBE], V95%: 98.5%). Average maximum doses to the heart, esophagus, and stomach were 3049, 631, and 894 cGy [RBE], respectively. Each field achieved high-dose rates, enabling beam delivery times ranging from 0.37 to 1.29 seconds per field. Conclusions: UHDR spread-out Bragg peak proton therapy enables conformal cardiac radioablation delivery on the order of a second per beam, which offers the opportunity to manage respiratory and cardiac motion in a single breath hold while achieving clinically acceptable plan quality.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
STAR in a Second: Ultra-High-Dose-Rate Spread-Out Bragg Peak Proton Therapy for Breath-Hold Stereotactic Arrhythmia Radioablation
Date Crossref
01/09/2026
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Cardiac Arrhythmias and TreatmentsAdvanced Radiotherapy TechniquesHepatocellular Carcinoma Treatment and Prognosis

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.